Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
ADPT
Adaptive Biotechnologies Corp
NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close
$29.84
· 2026-10-05
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap
$4.61B
Country
USA
RECENT INSIDER TRADES
2026-10-08
· RUBINSTEIN JULIE
(President and COO)
· OTHER
2026-10-08
· RUBINSTEIN JULIE
(President and COO)
· SELL
2026-10-08
· BOBULSKY SUSAN
(Chief Commercial Officer, MRD)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
320
Shares held
180,210,063
Value
$3.40B
Percent of shares outstanding
112.92%
As of quarter end
2026-06-30
RECENT NEWS
Adaptive Biotechnologies COO Julie Rubinstein sells $948,223 in stock
Adaptive Biotechnologies CCO Susan Bobulsky sells $193,320 in stock
Adaptive Biotechnologies COO Julie Rubinstein sells $1m in stock
Adaptive Biotechnologies CPO Francis Lo sells $3.2 million in stock
Adaptive Biotechnologies Highlights Role of Highly Sensitive MRD Testing in New International Myeloma Society Definition of Cure
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Adaptive Biotechnologies Corp (ADPT) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit